Elisabeth Leiderman - 22 Jun 2022 Form 4 Insider Report for bluebird bio, Inc. (BLUE)

Role
Director
Signature
/s/ Jason F. Cole, Attorney-in-Fact
Issuer symbol
BLUE
Transactions as of
22 Jun 2022
Transactions value $
$0
Form type
4
Date filed
23 Jun 2022, 18:08
Previous filing
28 Feb 2022
Next filing
09 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLUE Common Stock Award $0 +3.11K +33.21% $0.00 12.5K 22 Jun 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLUE Stock Option (right to buy) Award $0 +5K $0.00 5K 22 Jun 2022 Common Stock 5K $4.46 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units for common stock vest 100% on the earlier of June 22, 2023 or the date of the next annual meeting of stockholders.
F2 This option vests 100% on the earlier of June 22, 2023 or the date of the next annual meeting of stockholders.